91 related articles for article (PubMed ID: 20224269)
21. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.
D'Arena G; Tarnani M; Rumi C; Vaisitti T; Aydin S; De Filippi R; Perrone F; Pinto A; Chiusolo P; Deaglio S; Malavasi F; Laurenti L
Am J Hematol; 2007 Sep; 82(9):787-91. PubMed ID: 17534928
[TBL] [Abstract][Full Text] [Related]
23. Fludarabine and cladribine induce changes in surface proteins on human B-lymphoid cell lines involved with apoptosis, cell survival, and antitumor immunity.
Kohnke PL; Mactier S; Almazi JG; Crossett B; Christopherson RI
J Proteome Res; 2012 Sep; 11(9):4436-48. PubMed ID: 22839105
[TBL] [Abstract][Full Text] [Related]
24. Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft model.
Aydin S; Grabellus F; Eisele L; Möllmann M; Hanoun M; Ebeling P; Moritz T; Carpinteiro A; Nückel H; Sak A; Göthert JR; Dührsen U; Dürig J
Eur J Haematol; 2011 Jul; 87(1):10-9. PubMed ID: 21692849
[TBL] [Abstract][Full Text] [Related]
25. Discordance of ZAP-70 in patients with chronic lymphocytic leukemia.
Chaar BT; Schergen AK; Grosso LE
Int J Lab Hematol; 2008 Feb; 30(1):36-40. PubMed ID: 18190465
[TBL] [Abstract][Full Text] [Related]
26. Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with in vitro sensitivity to chlorambucil and purine analogs.
Morabito F; Filangeri M; Callea I; Sculli G; Callea V; Fracchiolla NS; Neri A; Brugiatelli M
Haematologica; 1997; 82(1):16-20. PubMed ID: 9107076
[TBL] [Abstract][Full Text] [Related]
27. Drug induction apoptosis assay as predictive value of chemotherapy response in patients with B-cell chronic lymphocytic leukemia.
Castejón R; Yebra M; Citores MJ; Villarreal M; García-Marco JA; Vargas JA
Leuk Lymphoma; 2009 Apr; 50(4):593-603. PubMed ID: 19373658
[TBL] [Abstract][Full Text] [Related]
28. Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine.
de la Fuente MT; Casanova B; Moyano JV; Garcia-Gila M; Sanz L; Garcia-Marco J; Silva A; Garcia-Pardo A
J Leukoc Biol; 2002 Mar; 71(3):495-502. PubMed ID: 11867687
[TBL] [Abstract][Full Text] [Related]
29. New prognostic markers in chronic lymphocytic leukemia.
Moreno C; Montserrat E
Blood Rev; 2008 Jul; 22(4):211-9. PubMed ID: 18448218
[TBL] [Abstract][Full Text] [Related]
30. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies.
Montillo M; Hamblin T; Hallek M; Montserrat E; Morra E
Haematologica; 2005 Mar; 90(3):391-9. PubMed ID: 15749671
[TBL] [Abstract][Full Text] [Related]
31. Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro.
Morabito F; Mangiola M; Rapezzi D; Zupo S; Oliva BM; Ferraris AM; Spriano M; Rossi E; Stelitano C; Callea V; Cutrona G; Ferrarini M
Haematologica; 2003 Aug; 88(8):864-73. PubMed ID: 12935974
[TBL] [Abstract][Full Text] [Related]
32. In vitro modulation of bcl-2 protein expression, drug-induced apoptosis and cytotoxicity by interleukin-10 in chronic lymphocytic leukemia.
Morabito F; Filangeri M; Sculli G; Oliva B
Haematologica; 1998 Nov; 83(11):1046-8. PubMed ID: 9864930
[TBL] [Abstract][Full Text] [Related]
33. Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia.
Saka B; Aktan M; Sami U; Oner D; Sanem O; Dinçol G
Clin Lab Haematol; 2006 Feb; 28(1):30-5. PubMed ID: 16430457
[TBL] [Abstract][Full Text] [Related]
34. The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia.
Del Poeta G; Del Principe MI; Consalvo MA; Maurillo L; Buccisano F; Venditti A; Mazzone C; Bruno A; Gianní L; Capelli G; Lo Coco F; Cantonetti M; Gattei V; Amadori S
Cancer; 2005 Dec; 104(12):2743-52. PubMed ID: 16284990
[TBL] [Abstract][Full Text] [Related]
35. Nucleoside transporters, bcl-2 and apoptosis in CLL cells exposed to nucleoside analogues in vitro.
Petersen AJ; Brown RD; Gibson J; Pope B; Luo XF; Schutz L; Wiley JS; Joshua DE
Eur J Haematol; 1996 Apr; 56(4):213-20. PubMed ID: 8641389
[TBL] [Abstract][Full Text] [Related]
36. Ajoene, a garlic-derived natural compound, enhances chemotherapy-induced apoptosis in human myeloid leukaemia CD34-positive resistant cells.
Ahmed N; Laverick L; Sammons J; Zhang H; Maslin DJ; Hassan HT
Anticancer Res; 2001; 21(5):3519-23. PubMed ID: 11848518
[TBL] [Abstract][Full Text] [Related]
37. Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia.
Del Giudice I; Morilla A; Osuji N; Matutes E; Morilla R; Burford A; Maravelaki S; Owusu-Ankomah K; Swansbury J; A'Hern R; Brito-Babapulle V; Catovsky D
Cancer; 2005 Nov; 104(10):2124-32. PubMed ID: 16211545
[TBL] [Abstract][Full Text] [Related]
38. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586
[TBL] [Abstract][Full Text] [Related]
39. Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradication.
Bosch F; Ferrer A; Villamor N; González M; Briones J; González-Barca E; Abella E; Gardella S; Escoda L; Pérez-Ceballos E; Asensi A; Sayas MJ; Font L; Altés A; Muntañola A; Bertazzoni P; Rozman M; Aymerich M; Giné E; Montserrat E
Clin Cancer Res; 2008 Jan; 14(1):155-61. PubMed ID: 18172266
[TBL] [Abstract][Full Text] [Related]
40. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
Abousamra NK; El-Din MS; Azmy E
Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]